New York, NY, United States of America

Peerbridge Health, Inc.


USPTO Granted Patents = 5

% Expired Patents = 40.0


Trademarks = 13

Forward Citations = 391

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal Angelo Joseph Acquista (5 out of 7 patents)

silverMedal John R Shambroom (3 out of 7 patents)

bronzeMedal Leung-Hang Ma (3 out of 3 patents)

4.  Keith Sproat (2 out of 3 patents)

5.  Arthur Bertolero (2 out of 2 patents)

6.  Benjamin Mughal (2 out of 2 patents)

7.  Robert Joseph Bouthillier (2 out of 2 patents)

8.  Steven Geyster (2 out of 2 patents)

9.  Michael Peter Fusaro (2 out of 6 patents)

10.  Avi Kometz (1 out of 1 patent)

11.  Elizabeth Goodrich (1 out of 11 patents)

12.  Elisabeth Goodrich (1 out of 1 patent)

13.  Dean Owens (1 patent)

14.  Drew Sunstein (1 patent)

15.  James Edward Peret (0 patent)


5 patents:

Company Overview
Peerbridge Health is a medical technology company focused on developing remote patient monitoring solutions. Their flagship product, the Peerbridge Cor, is a wearable patch that continuously monitors vital signs and detects abnormal heart rhythms. The company aims to improve patient outcomes and reduce healthcare costs through innovative technology.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#1,192 in New York, NY

#3,131 in New York

#51,620 in US

New York, NY (US)
New York, NY, United States of America
Forward Citations = 391

12 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Peerbridge Health, Inc.. Retrieved from https://idiyas.com/company/peerbridge-health

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…